CRP and cardiovascular disorder: Observational studies have shown that low-grade inflammation, as assessed by highly sensitive C-reactive protein (CRP), was highly predictive of cardiovascular disease (CVD) in the general population (41, 42), advanced chronic kidney disease patients (43) and dialysis-dependent patients (44).